Eupatorium Capilifolium (Lam.) Small Ex Porter & Britton (Asteraceae: Eupatorieae), REKAMAN BARU untuk FLORA JAWA

Sebanyak 227 jenis tumbuhan Asteraceae terdapat di Pulau Jawa berdasarkan Flora of Java. Namun, suku Asteraceae di Pulau Jawa belum banyak ditinjau kembali sejak buku tersebut terbit 51 tahun yang lalu, sehingga memungkinkan adanya jenis-jenis tambahan yang belum terekam. Penelitian ini bertujuan untuk memberikan informasi adanya jenis tambahan yang terdapat di Pulau Jawa. Penelitian dilakukan menggunakan metode jelajah di Labuan (Banten), Bogor (Jawa Barat), Malang, dan Situbondo (Jawa Timur). Eupatorium capillifolium (Lam.) Small ex Porter & Britton merupakan rekaman baru yang dapat melengkapi flora Jawa. Jenis tersebut dikelompokkan ke dalam puak Eupatorieae

Catatan Tentang Solanum Diphyllum L. (Solanaceae) Ternaturalisasi di Pulau Jawa

Solanum merupakan salah satu marga terbesar pada kelompok tumbuhan Angiospermae. Marga tersebut terdiri dari 1400 jenis yang terdistribusi di kawasan tropis dan subtropis. Banyak anggotanya yang memiliki nilai ekonomi tinggi, sehingga telah dibudidayakan secara luas sebagai tanaman pangan, sayuran, tumbuhan obat, dan tanaman hias. Oleh sebab itu, beberapa di antaranya telah diintroduksi ke Pulau Jawa sejak lama. Sebanyak 24 jenis Solanum telah tercatat dalam buku Flora of Java vol. 2. Meskipun demikian, masih memungkinkan adanya jenis-jenis lain yang belum terekam dalam buku tersebut. Penelitian ini bertujuan untuk memberikan informasi mengenai jenis tambahan yang telah ternaturalisasi di Pulau Jawa. Pengamatan dilakukan di beberapa lokasi di Jawa Barat, Jawa Tengah, dan Jawa Timur pada tahun 2015 hingga 2017. Solanum diphyllum telah dikoleksi dari Bogor (Darmaga), Bandung (Taman Sari dan Pasir Impun), Sumedang (Jatinangor), Wonogiri (Desa Johunut), Semarang (Desa Mesu), Trenggalek (Desa Watulimo), Situbondo (Desa Wringin Anom dan Banyuputih), Bondowoso (Desa Bandilan), dan Sumenep (Desa Pakong). Jenis ini memiliki potensi untuk dimanfaatkan sebagai tumbuhan obat. Tumbuhan ini ditemukan tumbuh meliar di semua lokasi pengamatan dan keberadaannya perlu diperhatikan karena jenis tersebut merupakan tumbuhan asing invasif di kawasan lain

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe